Detalhe da pesquisa
1.
Dose/schedule-adjusted Rd-R vs continuous Rd for elderly, intermediate-fit patients with newly diagnosed multiple myeloma.
Blood
; 137(22): 3027-3036, 2021 06 03.
Artigo
Inglês
| MEDLINE | ID: mdl-33739404
2.
Autologous stem cell transplantation in multiple myeloma patients over 70 years: A GIMEMA Lazio Working Group experience in a retrospective case-control study.
Eur J Haematol
; 109(3): 250-256, 2022 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-35617025
3.
Response to "Conditioning with melphalan (Mel) 200 mg/m2 and subsequent autologous stem cell transplantation improves progression free survival and overall survival in elderly multiple myeloma patients compared to standard of care".
Eur J Haematol
; 110(2): 221, 2023 02.
Artigo
Inglês
| MEDLINE | ID: mdl-36300853
4.
Immunotactoid glomerulopathy and chronic lymphocytic leukemia: The need for a multidisciplinary approach.
EJHaem
; 4(1): 266-268, 2023 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-36819169
5.
Consensus for Flow Cytometry Clinical Report on Multiple Myeloma: A Multicenter Harmonization Process Merging Laboratory Experience and Clinical Needs.
Cancers (Basel)
; 15(7)2023 Mar 30.
Artigo
Inglês
| MEDLINE | ID: mdl-37046720
6.
Daratumumab combined with dexamethasone and lenalidomide or bortezomib in relapsed/refractory multiple myeloma (RRMM) patients: Report from the multiple myeloma GIMEMA Lazio group.
EJHaem
; 3(1): 121-128, 2022 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-35846211
7.
Pulmonary arterial hypertension in a patient with multiple myeloma during carfilzomib treatment: in search of better management.
Tumori
; 107(6): NP37-NP40, 2021 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-33525991
8.
Onset and Progression of Precancerous Lesions on Gastric Mucosa of Patients Treated for Gastric Lymphoma.
J Gastrointestin Liver Dis
; 29(1): 27-31, 2020 Mar 13.
Artigo
Inglês
| MEDLINE | ID: mdl-32176756
9.
Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study.
Lancet Haematol
; 7(6): e456-e468, 2020 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-32359506